# NCR Voyix Corp: overview

VYX · NYSE · CIK 70866 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vyx.md) · [Financials](/companies/vyx/financials.md) · [Filings](/companies/vyx/filings.md) · [Insiders](/companies/vyx/insiders.md)

Latest reported revenue: [$523.0m](/filings/0000070866-26-000030.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000070866-26-000030).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [708](/filings/0000070866-25-000088.md) | [682](/filings/0000070866-25-000010.md) | [612](/filings/0000070866-26-000017.md) | [660](/filings/0000070866-26-000030.md) | [684](/filings/0000070866-25-000088.md) | [720 d](/filings/0000070866-26-000006.md) | [606](/filings/0000070866-26-000017.md) | [523](/filings/0000070866-26-000030.md) |
| Gross margin | % | [23.4%](/filings/0000070866-25-000010.md) | [21.8%](/filings/0000070866-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [2.3%](/filings/0000070866-25-000088.md) | [0.3%](/filings/0000070866-25-000010.md) | [(3.4%)](/filings/0000070866-26-000017.md) | [2.0%](/filings/0000070866-26-000030.md) | [2.2%](/filings/0000070866-25-000088.md) | [2.4% d](/filings/0000070866-26-000006.md) | [(3.1%)](/filings/0000070866-26-000017.md) | [2.7%](/filings/0000070866-26-000030.md) |
| Net margin | % | [152.8%](/filings/0000070866-25-000088.md) | [(1.6%)](/filings/0000070866-25-000010.md) | [(2.8%)](/filings/0000070866-26-000017.md) | [0.0%](/filings/0000070866-26-000030.md) | [(2.8%)](/filings/0000070866-25-000088.md) | [13.6% d](/filings/0000070866-26-000006.md) | [(0.8%)](/filings/0000070866-26-000017.md) | [0.4%](/filings/0000070866-26-000030.md) |
| Diluted EPS | $ per share | [7.41](/filings/0000070866-25-000088.md) | [(0.10)](/filings/0000070866-25-000010.md) | [(0.15)](/filings/0000070866-26-000017.md) | [(0.03)](/filings/0000070866-26-000030.md) | [(0.16)](/filings/0000070866-25-000088.md) | not reported | [(0.06)](/filings/0000070866-26-000017.md) | [(0.01)](/filings/0000070866-26-000030.md) |
| Free cash flow | $m | [9.0 d](/filings/0000070866-25-000088.md) | [(177) d](/filings/0000070866-26-000006.md) | [(81.0)](/filings/0000070866-26-000017.md) | [(284) d](/filings/0000070866-26-000030.md) | [(48.0) d](/filings/0000070866-25-000088.md) | [(86.0) d](/filings/0000070866-26-000006.md) | [6.0](/filings/0000070866-26-000017.md) | [(24.0) d](/filings/0000070866-26-000030.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,692](/filings/0000070866-24-000014.md) | [3,174](/filings/0000070866-25-000010.md) | [3,166](/filings/0000070866-26-000006.md) | [2,818](/filings/0000070866-26-000006.md) | [2,687](/filings/0000070866-26-000006.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [0.7%](/filings/0000070866-24-000014.md) | [(1.6%)](/filings/0000070866-25-000010.md) | [(4.2%)](/filings/0000070866-26-000006.md) | [(1.3%)](/filings/0000070866-26-000006.md) | [1.0%](/filings/0000070866-26-000006.md) |
| Net margin | % | [2.6%](/filings/0000070866-24-000014.md) | [1.9%](/filings/0000070866-25-000010.md) | [(13.5%)](/filings/0000070866-26-000006.md) | [34.0%](/filings/0000070866-26-000006.md) | [2.3%](/filings/0000070866-26-000006.md) |
| Diluted EPS | $ per share | [0.62](/filings/0000070866-24-000014.md) | [0.32](/filings/0000070866-25-000010.md) | [(3.16)](/filings/0000070866-26-000006.md) | [6.52](/filings/0000070866-26-000006.md) | [0.30](/filings/0000070866-26-000006.md) |
| Free cash flow | $m | [903](/filings/0000070866-24-000014.md) | [335](/filings/0000070866-25-000010.md) | [564](/filings/0000070866-26-000006.md) | [(162)](/filings/0000070866-26-000006.md) | [(375)](/filings/0000070866-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vyx/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2019-09-20 | [Blackstone Holdings III L.P.](/insiders/1404073.md) | 10% owner | Sale (S) | 7,968 | $32.75 | $261.0k | [Form 4](/filings/0000899243-19-024060.md) |
| 2019-09-20 | [Blackstone Holdings III L.P.](/insiders/1404073.md) | 10% owner | Sale (S) | 2,312,643 | $32.75 | $75.7m | [Form 4](/filings/0000899243-19-024060.md) |
| 2019-09-20 | [Blackstone Holdings III L.P.](/insiders/1404073.md) | 10% owner | Sale (S) | 13,409 | $32.75 | $439.1k | [Form 4](/filings/0000899243-19-024060.md) |
| 2019-09-20 | [Blackstone Holdings III L.P.](/insiders/1404073.md) | 10% owner | Sale (S) | 6,795,946 | $32.75 | $222.6m | [Form 4](/filings/0000899243-19-024060.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $184.3m | 22,559,376 |  | Added +548,907 |
| [Greenhouse Funds LLLP](/funds/1626220.md) | 2026-06-30 | $162.6m | 19,897,615 |  | Added +185,201 |
| [SHAPIRO CAPITAL MANAGEMENT LLC](/funds/1177244.md) | 2026-06-30 | $88.5m | 10,834,553 |  | Added +508,793 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $88.3m | 10,808,473 |  | Added +212,438 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $50.8m | 6,223,329 |  | Added +2,898,101 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $50.7m | 6,210,604 |  | Reduced −6,991 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $50.4m | 6,173,732 |  | Reduced −289,762 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $49.7m | 6,079,117 |  | Added +330,234 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $49.2m | 6,017,676 |  | Reduced −252,303 |
| [First Pacific Advisors, LP](/funds/1377581.md) | 2026-06-30 | $44.2m | 5,413,012 |  | Added +7,930 |

## Recent filings

[All 1,749 filings](/companies/vyx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 07:31 ET | [10-Q](/filings/0000070866-26-000030.md) | Quarterly report, period 2026-06-30 | 0000070866-26-000030 |
| 2026-08-05 | 06:31 ET | [8-K](/filings/0000070866-26-000029.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070866-26-000029 |
| 2026-06-08 | 16:34 ET | [8-K](/filings/0000070866-26-000023.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000070866-26-000023 |
| 2026-05-07 | 07:30 ET | [10-Q](/filings/0000070866-26-000017.md) | Quarterly report, period 2026-03-31 | 0000070866-26-000017 |
| 2026-05-07 | 06:32 ET | [8-K](/filings/0000070866-26-000016.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070866-26-000016 |
| 2026-04-21 | 16:02 ET | [DEF 14A](/filings/0000070866-26-000010.md) | Proxy statement, period 2026-06-03 | 0000070866-26-000010 |
| 2026-02-26 | 07:32 ET | [10-K](/filings/0000070866-26-000006.md) | Annual report, period 2025-12-31 | 0000070866-26-000006 |
| 2026-02-26 | 06:32 ET | [8-K](/filings/0000070866-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070866-26-000005 |
| 2025-11-06 | 06:49 ET | [10-Q](/filings/0000070866-25-000088.md) | Quarterly report, period 2025-09-30 | 0000070866-25-000088 |
| 2025-11-06 | 06:46 ET | [8-K](/filings/0000070866-25-000087.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000070866-25-000087 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000070866-26-000006.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/6dcb14af-8aa5-4496-bef8-8d4f91e28847)

## About the filer

- CIK: 70866
- Tickers: VYX, NCRRP
- Exchange: NYSE
- SIC code: 3578 Calculating & Accounting Machines (No Electronic Computers)
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.